Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)

PURPOSE: Evaluate patients’ and nurses’ experiences, including injection problem frequency, with the somatostatin analogues (SSAs) lanreotide autogel(®) (Somatuline(®) autogel(®), deep subcutaneous) and octreotide long-acting release (LAR) (Sandostatin(®) LAR(®), intramuscular) when treating gastroe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ström, Torbjörn, Kozlovacki, Gordana, Myrenfors, Peter, Almquist, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815752/
https://www.ncbi.nlm.nih.gov/pubmed/31695341
http://dx.doi.org/10.2147/PPA.S213472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815752/
https://www.ncbi.nlm.nih.gov/pubmed/31695341
http://dx.doi.org/10.2147/PPA.S213472

Ejemplares similares